Delivery Order SPE2DB24D3013-SPE2DB25FFNVD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jatenzo 237 mg capsules (120 count) under a firm fixed-price contract with a ceiling value of $1,131.87. The contract, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $2,418.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 237 mg capsules of JATENZO, a medication used to treat testosterone deficiency. The delivery order, issued under an indefinite-delivery/indefinite-quantity contract vehicle, calls for 120 capsules to be shipped to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support the Agency's medical supply needs. No subcontractors or set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.63 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, was made without set-aside designation through open competition using firm fixed price contracting. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $8,442.15 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.16 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg, a testosterone replacement therapy medication. The contract was competitively awarded without set-aside designation on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and...
- The Defense Logistics Agency awarded a $1,131.88 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jatenzo 158 mg capsules (120-count unit). This firm fixed-price delivery order, which is a child contract under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The award utilized no set-aside designation and was competitively awarded through open...
- This is a $1,182.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through January 16, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $3,643.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of JATENZO 237 MG. The order is to be fulfilled by Amerisourcebergen's Corporate Office Division facility in Conshohocken, Pennsylvania by July 7, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order for testosterone capsules supports DOD medical readiness programs. No subcontractors or set...
- This is a $2,312.78 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract has an ultimate completion date of May 16, 2025. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part...
- This is a $5,265.57 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of JATENZO 237 MG capsules, a pharmaceutical product, with a performance period ending on July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides comprehensive global...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNVDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,263.74 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jatenzo is a testosterone replacement therapy medication used to treat hypogonadism in adult males, addressing a critical pharmaceutical need within the Defense Health Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support framework enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal portfolio demonstrates its established capability to fulfill specialized pharmaceutical requirements for military and veteran healthcare systems through competitively awarded contracts with consistent firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/29/25 |